Search
for
Sort by
Research 331–360 of 1000+
- Clinical application of 5α-reductase inhibitors
- Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti‐androgens
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Female Androgenetic Alopecia: An Update on Diagnosis and Management
- Female pattern alopecia: current perspectives
- Male pattern baldness: current treatments, future prospects
- 5-Alpha reductase deficiency
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version
- Promising therapies for treating and/or preventing androgenic alopecia.
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Treatment options for alopecia: an update, looking to the future
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Androgens in women
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- Mesotherapy: What is new?
- Hair Biology
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Neurosteroids Are Endogenous Neuroprotectants in an Ex Vivo Glaucoma Model
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Gas chromatography/mass spectrometry based hair steroid profiling may reveal pathogenesis in hair follicles of the scalp
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- 5α-Reductase inhibitors in androgenetic alopecia
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase